The WHO claimed Thursday that it has fielded several stories of faux semaglutide — the Energetic ingredient in Novo Nordisk's Wegovy and Ozempic — in all geographic locations of the planet since 2022. The patent for semaglutide, the active ingredient in Ozempic and Wegovy, isn’t envisioned to expire until around 2031 on the earliest. in con